CN Stock MarketDetailed Quotes

300601 Shenzhen Kangtai Biological Products

Watchlist
  • 19.18
  • -0.49-2.49%
Trading May 23 11:16 CST
21.42BMarket Cap30.16P/E (TTM)

Shenzhen Kangtai Biological Products Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-39.65%451.66M
10.14%3.48B
-3.92%2.46B
-5.32%1.73B
-14.12%748.38M
-13.55%3.16B
7.90%2.57B
73.72%1.83B
214.60%871.43M
61.51%3.65B
Operating revenue
-39.65%451.66M
10.14%3.48B
-3.92%2.46B
-5.32%1.73B
-14.12%748.38M
-13.55%3.16B
7.90%2.57B
73.72%1.83B
214.60%871.43M
61.51%3.65B
Other operating revenue
----
-61.23%10.9M
----
-82.59%1.13M
----
1,107.84%28.11M
----
1,520.31%6.47M
----
0.38%2.33M
Total operating cost
-16.40%420.22M
-1.84%2.57B
-12.56%1.73B
-10.00%1.18B
-10.46%502.64M
22.72%2.62B
63.33%1.98B
83.61%1.31B
111.45%561.39M
39.12%2.13B
Operating cost
-31.75%71.96M
7.55%537.67M
3.29%343.81M
-5.75%229.38M
-13.83%105.44M
-49.32%499.95M
-8.83%332.86M
48.65%243.38M
207.28%122.35M
335.88%986.43M
Operating tax surcharges
-33.70%2.76M
25.02%25.62M
-2.38%15.19M
2.67%11.59M
-5.43%4.17M
1.66%20.49M
0.94%15.56M
27.31%11.29M
66.50%4.41M
39.43%20.16M
Operating expense
-38.37%159.76M
13.36%1.23B
-4.64%845.52M
-1.75%596.44M
-10.23%259.2M
87.87%1.09B
81.70%886.66M
75.70%607.04M
138.14%288.73M
-34.17%578.24M
Administration expense
42.33%73.52M
19.70%275.53M
-8.33%171.35M
-22.19%100.05M
-10.37%51.65M
-9.08%230.18M
15.56%186.91M
25.78%128.57M
14.63%57.63M
50.33%253.17M
Financial expense
301.86%4.61M
92.63%-1.56M
91.24%-1.89M
92.53%-1.37M
68.88%-2.28M
64.24%-21.15M
45.28%-21.6M
40.88%-18.29M
50.29%-7.34M
-176.44%-59.17M
-Interest expense (Financial expense)
19.27%32.78M
4.35%113.71M
3.65%83.88M
3.27%55.51M
4.74%27.48M
99.90%108.97M
231.74%80.93M
2,632.07%53.76M
8,394.19%26.24M
2,231.92%54.51M
-Interest Income (Financial expense)
5.19%-28.26M
12.82%-115.62M
18.29%-86.04M
23.19%-56.93M
15.78%-29.81M
-15.41%-132.62M
-63.50%-105.3M
-122.65%-74.12M
-130.63%-35.4M
-377.57%-114.91M
Research and development
27.40%107.61M
-37.55%500.75M
-38.28%358.5M
-28.01%244.81M
-11.65%84.47M
126.34%801.86M
161.34%580.88M
171.59%340.07M
44.24%95.6M
32.65%354.26M
Credit Impairment Loss
7.93%-12.64M
67.61%-12.79M
-52.85%-38.83M
-72.69%-37.52M
-82.63%-13.73M
-278.02%-39.48M
-258.79%-25.4M
-535.76%-21.73M
-995.81%-7.52M
49.01%-10.45M
Asset Impairment Loss
96.02%-345.73K
86.75%-118.79M
90.91%-44.03M
90.38%-43.17M
14.76%-8.7M
-478.53%-896.49M
-1,680.90%-484.29M
-9,032.34%-448.71M
-421.33%-10.2M
-3,614.66%-154.96M
Other net revenue
2,867.34%38.5M
104.78%40.96M
108.53%36.76M
103.90%16.69M
-108.11%-1.39M
-1,184.17%-857.29M
-1,438.30%-431.19M
-952.81%-427.55M
-5.27%17.16M
-240.74%-66.76M
Fair value change income
--782.67K
-93.95%192.2K
-66.33%120.99K
-92.76%24.41K
--0
--3.18M
101.27%359.36K
101.16%337.06K
-99.15%93.63K
--0
Invest income
--0
79.88%1.7M
1,699.78%1.7M
--1.7M
--1.47M
-96.82%944.05K
-99.83%94.35K
--0
----
117.21%29.71M
Asset deal income
--71.01K
-1,156.20%-1.35M
-426.13%-499.78K
464.11%874.78K
--0
370.38%127.43K
592.16%153.25K
280.19%155.07K
----
109.28%27.09K
Other revenue
158.80%50.63M
131.05%171.99M
51.87%118.3M
123.53%94.79M
-43.76%19.56M
8.03%74.44M
103.83%77.89M
24.76%42.4M
812.73%34.79M
141.30%68.91M
Operating profit
-71.38%69.94M
398.80%948.92M
403.80%768.75M
541.82%566.36M
-25.32%244.35M
-121.87%-317.57M
-87.25%152.59M
-77.24%88.24M
1,004.86%327.2M
87.30%1.45B
Add:Non operating Income
19.44%229.34K
-84.58%1.02M
-91.14%538.8K
-92.34%378.05K
-14.42%192K
259.80%6.61M
269.70%6.08M
237.60%4.94M
19.72%224.35K
-65.45%1.84M
Less:Non operating expense
84.13%5.01M
-64.76%9.62M
-72.16%4.29M
-65.37%2.97M
-49.84%2.72M
83.91%27.29M
17.62%15.4M
-30.08%8.59M
14,572.87%5.43M
79.19%14.84M
Total profit
-73.05%65.16M
378.00%940.32M
433.95%765M
566.45%563.76M
-24.90%241.82M
-123.50%-338.25M
-87.91%143.27M
-77.56%84.59M
981.81%322M
86.33%1.44B
Less:Income tax cost
-69.39%11.13M
138.44%79.02M
213.49%67.95M
248.50%53.33M
-24.90%36.36M
-216.87%-205.54M
-140.25%-59.87M
-188.93%-35.91M
949.59%48.41M
88.65%175.87M
Net profit
-73.70%54.03M
FLtoP861.3M
243.13%697.05M
323.58%510.43M
-24.90%205.46M
SL-132.71M
-80.40%203.15M
-64.19%120.5M
987.71%273.59M
86.01%1.26B
Net profit from continuing operation
-73.70%54.03M
749.02%861.3M
243.13%697.05M
323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.5M
987.71%273.59M
86.01%1.26B
Less:Minority Profit
---36.97K
----
----
----
--0
----
----
----
----
----
Net profit of parent company owners
-73.69%54.07M
749.02%861.3M
243.13%697.05M
323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.5M
987.71%273.59M
86.01%1.26B
Earning per share
Basic earning per share
-72.22%0.05
741.67%0.77
156.75%0.6234
163.00%0.4563
-55.00%0.18
-106.49%-0.12
-84.00%0.2428
-64.86%0.1735
984.01%0.4
79.61%1.85
Diluted earning per share
-72.22%0.05
741.67%0.77
156.75%0.6234
163.00%0.4563
-55.00%0.18
-106.59%-0.12
-83.67%0.2428
-64.34%0.1735
998.90%0.4
80.20%1.82
Other composite income
Total composite income
-73.70%54.03M
749.02%861.3M
243.13%697.05M
323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.5M
987.71%273.59M
86.01%1.26B
Total composite income of parent company owners
-73.69%54.07M
749.02%861.3M
243.13%697.05M
323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.5M
987.71%273.59M
86.01%1.26B
Total composite income of minority owners
---36.97K
----
----
----
----
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -39.65%451.66M10.14%3.48B-3.92%2.46B-5.32%1.73B-14.12%748.38M-13.55%3.16B7.90%2.57B73.72%1.83B214.60%871.43M61.51%3.65B
Operating revenue -39.65%451.66M10.14%3.48B-3.92%2.46B-5.32%1.73B-14.12%748.38M-13.55%3.16B7.90%2.57B73.72%1.83B214.60%871.43M61.51%3.65B
Other operating revenue -----61.23%10.9M-----82.59%1.13M----1,107.84%28.11M----1,520.31%6.47M----0.38%2.33M
Total operating cost -16.40%420.22M-1.84%2.57B-12.56%1.73B-10.00%1.18B-10.46%502.64M22.72%2.62B63.33%1.98B83.61%1.31B111.45%561.39M39.12%2.13B
Operating cost -31.75%71.96M7.55%537.67M3.29%343.81M-5.75%229.38M-13.83%105.44M-49.32%499.95M-8.83%332.86M48.65%243.38M207.28%122.35M335.88%986.43M
Operating tax surcharges -33.70%2.76M25.02%25.62M-2.38%15.19M2.67%11.59M-5.43%4.17M1.66%20.49M0.94%15.56M27.31%11.29M66.50%4.41M39.43%20.16M
Operating expense -38.37%159.76M13.36%1.23B-4.64%845.52M-1.75%596.44M-10.23%259.2M87.87%1.09B81.70%886.66M75.70%607.04M138.14%288.73M-34.17%578.24M
Administration expense 42.33%73.52M19.70%275.53M-8.33%171.35M-22.19%100.05M-10.37%51.65M-9.08%230.18M15.56%186.91M25.78%128.57M14.63%57.63M50.33%253.17M
Financial expense 301.86%4.61M92.63%-1.56M91.24%-1.89M92.53%-1.37M68.88%-2.28M64.24%-21.15M45.28%-21.6M40.88%-18.29M50.29%-7.34M-176.44%-59.17M
-Interest expense (Financial expense) 19.27%32.78M4.35%113.71M3.65%83.88M3.27%55.51M4.74%27.48M99.90%108.97M231.74%80.93M2,632.07%53.76M8,394.19%26.24M2,231.92%54.51M
-Interest Income (Financial expense) 5.19%-28.26M12.82%-115.62M18.29%-86.04M23.19%-56.93M15.78%-29.81M-15.41%-132.62M-63.50%-105.3M-122.65%-74.12M-130.63%-35.4M-377.57%-114.91M
Research and development 27.40%107.61M-37.55%500.75M-38.28%358.5M-28.01%244.81M-11.65%84.47M126.34%801.86M161.34%580.88M171.59%340.07M44.24%95.6M32.65%354.26M
Credit Impairment Loss 7.93%-12.64M67.61%-12.79M-52.85%-38.83M-72.69%-37.52M-82.63%-13.73M-278.02%-39.48M-258.79%-25.4M-535.76%-21.73M-995.81%-7.52M49.01%-10.45M
Asset Impairment Loss 96.02%-345.73K86.75%-118.79M90.91%-44.03M90.38%-43.17M14.76%-8.7M-478.53%-896.49M-1,680.90%-484.29M-9,032.34%-448.71M-421.33%-10.2M-3,614.66%-154.96M
Other net revenue 2,867.34%38.5M104.78%40.96M108.53%36.76M103.90%16.69M-108.11%-1.39M-1,184.17%-857.29M-1,438.30%-431.19M-952.81%-427.55M-5.27%17.16M-240.74%-66.76M
Fair value change income --782.67K-93.95%192.2K-66.33%120.99K-92.76%24.41K--0--3.18M101.27%359.36K101.16%337.06K-99.15%93.63K--0
Invest income --079.88%1.7M1,699.78%1.7M--1.7M--1.47M-96.82%944.05K-99.83%94.35K--0----117.21%29.71M
Asset deal income --71.01K-1,156.20%-1.35M-426.13%-499.78K464.11%874.78K--0370.38%127.43K592.16%153.25K280.19%155.07K----109.28%27.09K
Other revenue 158.80%50.63M131.05%171.99M51.87%118.3M123.53%94.79M-43.76%19.56M8.03%74.44M103.83%77.89M24.76%42.4M812.73%34.79M141.30%68.91M
Operating profit -71.38%69.94M398.80%948.92M403.80%768.75M541.82%566.36M-25.32%244.35M-121.87%-317.57M-87.25%152.59M-77.24%88.24M1,004.86%327.2M87.30%1.45B
Add:Non operating Income 19.44%229.34K-84.58%1.02M-91.14%538.8K-92.34%378.05K-14.42%192K259.80%6.61M269.70%6.08M237.60%4.94M19.72%224.35K-65.45%1.84M
Less:Non operating expense 84.13%5.01M-64.76%9.62M-72.16%4.29M-65.37%2.97M-49.84%2.72M83.91%27.29M17.62%15.4M-30.08%8.59M14,572.87%5.43M79.19%14.84M
Total profit -73.05%65.16M378.00%940.32M433.95%765M566.45%563.76M-24.90%241.82M-123.50%-338.25M-87.91%143.27M-77.56%84.59M981.81%322M86.33%1.44B
Less:Income tax cost -69.39%11.13M138.44%79.02M213.49%67.95M248.50%53.33M-24.90%36.36M-216.87%-205.54M-140.25%-59.87M-188.93%-35.91M949.59%48.41M88.65%175.87M
Net profit -73.70%54.03MFLtoP861.3M243.13%697.05M323.58%510.43M-24.90%205.46MSL-132.71M-80.40%203.15M-64.19%120.5M987.71%273.59M86.01%1.26B
Net profit from continuing operation -73.70%54.03M749.02%861.3M243.13%697.05M323.58%510.43M-24.90%205.46M-110.50%-132.71M-80.40%203.15M-64.19%120.5M987.71%273.59M86.01%1.26B
Less:Minority Profit ---36.97K--------------0--------------------
Net profit of parent company owners -73.69%54.07M749.02%861.3M243.13%697.05M323.58%510.43M-24.90%205.46M-110.50%-132.71M-80.40%203.15M-64.19%120.5M987.71%273.59M86.01%1.26B
Earning per share
Basic earning per share -72.22%0.05741.67%0.77156.75%0.6234163.00%0.4563-55.00%0.18-106.49%-0.12-84.00%0.2428-64.86%0.1735984.01%0.479.61%1.85
Diluted earning per share -72.22%0.05741.67%0.77156.75%0.6234163.00%0.4563-55.00%0.18-106.59%-0.12-83.67%0.2428-64.34%0.1735998.90%0.480.20%1.82
Other composite income
Total composite income -73.70%54.03M749.02%861.3M243.13%697.05M323.58%510.43M-24.90%205.46M-110.50%-132.71M-80.40%203.15M-64.19%120.5M987.71%273.59M86.01%1.26B
Total composite income of parent company owners -73.69%54.07M749.02%861.3M243.13%697.05M323.58%510.43M-24.90%205.46M-110.50%-132.71M-80.40%203.15M-64.19%120.5M987.71%273.59M86.01%1.26B
Total composite income of minority owners ---36.97K------------------------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg